Mandate

Vinge advises Oriflame in relation to the groups change of domicile from Luxembourg to Switzerland

May 11, 2015

Vinge advises Oriflame in connection with the process of changing the group’s domicile from Luxembourg to Switzerland. As part of this process, Oriflame Holding AG, a wholly owned Swiss subsidiary of Oriflame Cosmetics S.A., has announced a share-for-share exchange transaction. The shares of Oriflame Holding are intended to be listed on the main market of Nasdaq Stockholm.

Erik Sjöman and Dain Hård Nevonen (partners, capital markets & public M&A) and Sabina Börjesson and Joel Wahlberg advise Oriflame. Mattias Schömer (partner, tax) and Tora Hansjons provide tax advice.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026